Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: A single institution experience

Journal of the American College of Surgeons

Volumn 216, Issue 1, 2013, Pages 41-49

  Wolf, Patrick S ^a   Park, James O ^a   Bao, Fei ^a   Allen, Peter J ^a   Dematteo, Ronald P ^a   Fong, Yuman ^a   Jarnagin, William R ^a   Kingham, T Peter ^a   Gönen, Mithat ^a   Kemeny, Nancy ^a   Shia, Jinru ^a   D'Angelica, Michael I ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

BMI; body mass index; colorectal cancer liver metastatsis; CRCLM; diabetes mellitus; DM; EORTC; European Organisation for Research and Treatment of Cancer; HAIP; hepatic artery infusional pump; odds ratio; OR

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BODY MASS; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; COHORT ANALYSIS; COLORECTAL CANCER; DIABETES MELLITUS; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; LIVER DISEASE; LIVER INJURY; LIVER METASTASIS; LIVER RESECTION; LIVER SINUSOIDAL DILATATION; LIVER TOXICITY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK ASSESSMENT; STEATOSIS; SURGICAL MORTALITY; TOXIC HEPATITIS; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; DRUG-INDUCED LIVER INJURY; FEMALE; FLUOROURACIL; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84871241124     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2012.08.030     Document Type: Article

References (25)

1. J.S. Tomlinson, W.R. Jarnagin, and R.P. DeMatteo Actual 10-year survival after resection of colorectal liver metastases defines cure J Clin Oncol 25 2007 4575 4580
2. M.A. Choti, J.V. Sitzmann, and M.F. Tiburi Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 2002 759 766
3. R. Parks, M. Gönen, and N. Kemeny Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents J Am Coll Surg 204 2007 753 761 discussion 761-763
4. G. Portier, D. Elias, and O. Bouche Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial J Clin Oncol 24 2006 4976 4982
5. B. Nordlinger, H. Sorbye, and B. Glimelius Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016
6. J.M. Cleary, K.T. Tanabe, and G.Y. Lauwers Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver Oncologist 14 2009 1095 1105
7. M. Karoui, C. Penna, and M. Amin-Hashem Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases Ann Surg 243 2006 1 7
8. J.N. Vauthey, T.M. Pawlik, and D. Ribero Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 2006 2065 2072
9. T. Aloia, M. Sebagh, and M. Plasse Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases J Clin Oncol 24 2006 4983 4990
10. L. Rubbia-Brandt, V. Audard, and P. Sartoretti Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Ann Oncol 15 2004 460 466
11. H. Nakano, E. Oussoultzoglou, and E. Rosso Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg 247 2008 118 124
12. P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
13. I.R. Wanless, and J.S. Lentz Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors Hepatology 12 1990 1106 1110
14. M. Cescon, G. Vetrone, and G.L. Grazi Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years Ann Surg 249 2009 995 1002
15. D.E. Kleiner, E.M. Brunt, and M. Van Natta Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
16. L. Rubbia-Brandt, G.Y. Lauwers, and H. Wang Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin- associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis Histopathology 56 2010 430 439
17. R.C. Martin 2nd, M.F. Brennan, and D.P. Jaques Quality of complication reporting in the surgical literature Ann Surg 235 2002 803 813
18. E.K. Abdalla, J.N. Vauthey, and L.M. Ellis Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg 239 2004 818 825 discussion 825-827
19. F.G. Fernandez, J.A. Drebin, and D.C. Linehan Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET) Ann Surg 240 2004 438 447 discussion 447-450
20. Y. Fong, J. Fortner, and R.L. Sun Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 1999 309 318 discussion 318-321
21. N. Kemeny, Y. Huang, and A.M. Cohen Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer N Engl J Med 341 1999 2039 2048
22. D.A. Kooby, Y. Fong, and A. Suriawinata Impact of steatosis on perioperative outcome following hepatic resection J Gastrointest Surg 7 2003 1034 1044
23. F. Schaffner, and H. Thaler Nonalcoholic fatty liver disease Prog Liver Dis 8 1986 283 298
24. A. Brouquet, S. Benoist, and C. Julie Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases Surgery 145 2009 362 371
25. D. Zorzi, A. Laurent, and T.M. Pawlik Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases Br J Surg 94 2007 274 286